Description

Fortive Faces Tariff Pressure As Hospital Capital Demand Stays Cautious!

Fortive Corporation reported a solid start to fiscal year 2026, delivering year-over-year core revenue growth of just over 5% and adjusted EBITDA growth of 13%, alongside a notable 25% increase in adjusted earnings per share. The company attributed part of its revenue growth to an approximate 150 basis point benefit from additional year-over-year selling days in the quarter. The results were driven by performance across its two main segments—Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS)—each exhibiting strength through price and volume growth, supported by solid demand in North America and a sequential improvement in Europe. Within IOS, growth was bolstered by professional instrumentation, facilities and asset lifecycle solutions, and gas detection products, with margin pressure largely stemming from product mix and tariff-related impacts. Fluke, a key brand within the segment, saw strong order volume growth exceeding revenue growth, reflecting resilience despite broader economic uncertainties.